600,000 Shares in Danaher Corporation $DHR Bought by Southpoint Capital Advisors LP

Southpoint Capital Advisors LP purchased a new stake in Danaher Corporation (NYSE:DHR) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 600,000 shares of the conglomerate’s stock, valued at approximately $113,760,000. Danaher accounts for about 2.3% of Southpoint Capital Advisors LP’s investment portfolio, making the stock its 19th biggest holding.

Other hedge funds and other institutional investors have also bought and sold shares of the company. JPL Wealth Management LLC bought a new stake in Danaher during the 3rd quarter worth approximately $25,000. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $26,000. Elevated Capital Advisors LLC bought a new stake in Danaher during the fourth quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher during the fourth quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $196.57 on Tuesday. The company has a market capitalization of $138.19 billion, a P/E ratio of 34.92, a price-to-earnings-growth ratio of 2.38 and a beta of 0.79. The company’s 50-day moving average is $186.29 and its 200 day moving average is $196.48. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.77 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. TD Cowen dropped their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Finally, Barclays cut their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.